Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

Details for Australian Patent Application No. 2007308067 (hide)

Owner PTC Therapeutics, Inc.

Inventors Miller, Langdon; Hirawat, Samit

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007308067

PCT Pub. Number WO2008/045566

Priority 60/851,450 12.10.06 US

Filing date 11 October 2007

Wipo publication date 17 April 2008

International Classifications

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/045566 Priority application(s): WO2008/045566

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007308078-System and method for providing a health score for a patient

2007308045-Protein kinase inhibitors and methods for using thereof